A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy

Pediatric Nephrology

Volumn 19, Issue 2, 2004, Pages 144-147

  Nakanishi, Koichi ^a   Sako, Mayumi ^a   Yata, Nahoko ^a   Aoyagi, Noriyuki ^a   Nozu, Kandai ^b   Tanaka, Ryojiro ^b   Iijima, Kazumoto ^c   Yoshikawa, Norishige ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Heavy proteinuria; Polymerase chain reaction; Promoter; Restriction fragment length polymorphism; Urinary protein excretion

Indexed keywords

ADENINE; ANGIOTENSINOGEN; CYTOSINE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADENINE; ADOLESCENT; ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CYTOSINE; FEMALE; GENOTYPE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEINURIA;

EID: 0842345524     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1350-7     Document Type: Article

References (28)

1. Emancipator SN, Gallo GR, Lamm ME (1985) IgA nephropathy: perspective on pathogenesis and classification. Clin Nephrol 24:161-179
2. Yoshikawa N, Ito H, Yoshiara S, Nakahara C, Yoshiya K, Hasegawa O, Matsuo T (1987) Clinical course of IgA nephropathy in children. J Pediatr 110:555-560
3. Yoshikawa N, Tanaka R, Iijima K (2001) Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 16:446-457
4. Yoshikawa N, Ito H, Nakamura H (1992) Prognostic factors in childhood IgA nephropathy. Nephron 60:60-67
5. Harden PN, Geddes C, Rowe PA, Mcllroy JH, Boulton-Jones M, Rodger RSC, Junor BJR, Briggs JD, Connell JMC, Jardine AG (1995) Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345:1540-1542
6. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O (1995) Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169
7. Hunley TE, Julian BA, Phillips JA III, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V (1996) Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577
8. Pei Y, Scholey J, Thai K, Suzuki M, Cattran D (1997) Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest 100:814-820
9. Stratta P, Caterina C, Ciccone G, Barolo S, Dall'Omo AM, Fasano ME, Mazzola G, Berutti S, Fop F, Curtoni ES, Piccoli G (1999) Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population. Am J Kidney Dis 33:1071-1079
10. Tanaka R, Iijima K, Murakami R, Koide M, Nakamura H, Yoshikawa N (1998) ACE gene polymorphism in childhood IgA nephropathy: association with clinicopathologic findings. Am J Kidney Dis 31:774-779
11. Maruyama K, Yoshida M, Nishio H, Shirakawa T, Kawamura T, Tanaka R, Nakamura H, Iijima K, Yoshikawa N (2001) Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 16:350-355
12. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A (1999) Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 33:108-115
13. Goto S, Narita I, Saito N, Watanabe Y, Yamazaki H, Sakatsume M, Shimada H, Nishi S, Ueno M, Akazawa K, Arakawa M, Gejyo F (2002) A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int 62:980-985
14. Churg J, Bernstein J, Glassock RJ (1995) Classification and atlas of glomerular diseases. In: Renal disease, 2nd edn. Igakushoin, Tokyo, pp 86-88
15. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, Yabana M, Watanabe Y, Sumida Y, Nagahara T, Ochiai H, Ishii M (1997) Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension 30:1325-1330
16. D'Amico G (1992) Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature. Am J Kidney Dis 20:315-323
17. Locatelli F, Marcelli D, Comelli M, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A (1996) Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. Nephrol Dial Transplant 11:461-467
18. Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M (1999) A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 10:101-109
19. Yoshikawa N, Ito H (1999) Long-term effect of prednisolone, azathioprine, heparin-warfarin and dipyridamole in severe childhood IgA nephropathy (abstract). J Am Soc Nephrol 10:185A
20. Julian BA, Quiggins PA, Thompson JS, Woodford SY, Gleason K, Wyatt RJ (1985) Familial IgA nephropathy. Evidence of an inherited mechanism of disease. N Engl J Med 312:202-208
21. Jennette JC, Wall SD, Wilkman AS (1985) Low incidence of IgA nephropathy in blacks. Kidney Int 28:944-950
22. Lapinski R, Perico N, Remuzzi A, Sangalli F, Benigni A, Remuzzi G (1996) Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol 7:653-660
23. Homma T, Hoover RL, Ichikawa I, Harris RC (1990) Angiotensin II (AII) induces hypertrophy and stimulates collagen production in cultured rat glomerular mesangial cell (MC) (abstract). Clin Res 38:358A
24. Wolf G, Mueller E, Stahl RA, Ziyadeh FN (1993) Angiotensin II induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 92:1366-1372
25. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM (1992) Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474
26. Wolf G, Haberstroh U, Neilson EG (1992) Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107
27. Coppo R, Amore A, Gianoglio B, Cacace G, Picciottio G, Roccatello D, Peruzzi L, Piccoli G, Filippi P (1993) Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis 21:593-602
28. Cattran DC, Greenwood C, Ritchie S (1994) Long-term benefits of angiotensin-converting-enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23:247-254